Search

The article reports on the concern raised by the advocacy group Public Citizen over the unethical aspect of involving premature infants in the study "Surfactant, Positive Pressure, and Oxygenation Randomized Trial (SUPPORT), sponsored by Great Britain's National Institutes of Health (NIH).

The article reports on an increased use of atypical antipsychotic drugs among children in the U.S.

The article reports on the reemergence of the discourse regarding the intent to build the 2010 federal health reform bill for single-payers in Vermont.

The article focuses on the U.S. Congress' consideration for the reauthorization of the Medical Device User Fee Act (MDUFA) in which the Food and Drug Administration (FDA) is required to collect application fees from companies seeking clearance to market new medical devices.

A reprint of an article about the Medical Board of California which appeared in the August 9, 2011 issue of "Public Citizen" is presented.

The article presents the national rate of serious disciplinary actions taken by state medical boards in the U.S. in 2010 using the data released by the Federation of State Medical Boards (FSMB).

The article reports on some changes in the U.S. health care in 2009 which includes the nomination of Tom Daschle as White House "health czar" and Secretary of the Department of Health and Human Services.

A letter is presented from Dr. Sidney Wolfe and staff researcher Alan Levine to Secretary Kathleen Sebelius of the U.S. Department of Health and Human Services in the urgency of health care database access of health worker records for the different health care institutions.

Several letters to the editor are presented in response to article in previous issues Including "Public Option Now!" in the July 20-27 2009 issue, "Subject to Debate," by Katha Pollitt in the June 15, 2009 issue, and "Tales of the Tent City," by Ben Ehrenreich in the June 22, 2009 issue.

Presents several letters to the editor related to articles published in the previous issue of the journal. Criticism of journalist Eric Alterman; Information related to San Francisco mayoral race, where City Supervisor Tom Ammiano is being pitted against Democrat Willie Brown; Discussion on Jacob S. Hacker's article titled "Bradley Does Healthcare."

Dr. Wolfe compares recent advertising claims of drug manufacturers with the National Academy of Sciences' drug efficacy studies. He stresses the need for several major revisions of drug advertising techniques and urges the FDA to assume surveillance over the content of material and presentations used by drug detail men. He also advocates that people should be encouraged to ask their doctors why a particular drug is being prescribed.

Chloramphenicol can inhibit protein synthesis in mammalian cell-free systems as effectively as it inhibits protein synthesis in analogous microbial systems. Significant inhibition in mammalian systems was obtained only when protein synthesis was stimulated by the addition of template RNA to the system, there being comparatively little inhibition of protein synthesis by ribosomes in the absence of stimulatory RNA. It is postulated that chloramphenicol may inhibit the function of messenger or template RNA by successfully competing for ribosomal binding sites, thereby preventing the attachment of RNA to ribosomes. The apparent discrepancy in the sensitivity of mammalian and microbial cells to chloramphenicol may be related to differences in turnover or stability of ribosomal template RNA rather than to intrinsic differences in mechanism of protein synthesis. These observations are in accord with the suggestion that protein synthesis in intact mammalian cells may be susceptible to chloramphenicol inhibition only at the time that new messenger or template RNA is being deposited on ribosomes and that more mature cells may be resistant because informative RNA already deposited on ribosomes is not accessible to chloramphenicol inhibition. The inhibitory effect of chloramphenicol on protein synthesis in proliferating cells may be an important factor in hematologic toxicity attributable to chloramphenicol.

The article focuses on a report from Public Citizen which documents concerns regarding the critical labeling of generic drugs in the U.S.

The article reports on the rise in the abuse and misuse of stimulant medications, which are usually used for treatment of attention deficit hyperactivity disorder (ADHD), in the U.S. as of August 2013.

The article focuses on a study, published in the medical journal "JAMA Internal Medicine," revealing the health risks involved in the use of colonoscopy for colorectal cancer screening in older people.

The article reports on a study by the U.S. Centers for Disease Control and Prevention (CDC) which revealed that a significant number of women may have undergone unnecessary Pap tests or cervical cancer screening.

The article reports on a study in Australia that was published in the September 2012 issue of the "American Journal of Psychiatry," which investigated the effect of non-drug therapies on elderly patients with dementia.